Tuesday, December 5, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Lewis, a Pain Specialist who has seen it all

    A conversation with Dr. Lewis, a Pain Specialist who has seen it all

    December 5, 2023
    A follow-on conversation with Drs. Lawhern & Nadeau, delving deeper into opioid mortality statistics

    A follow-on conversation with Drs. Lawhern & Nadeau, delving deeper into opioid mortality statistics

    December 3, 2023
    Joseph Parker

    A conversation with Dr. Parker, a model of physician advocacy

    December 2, 2023
    Dr. Amesh Adalja Discusses Flu Season and Trends in 2024

    Dr. Amesh Adalja Discusses Flu Season and Trends in 2024

    November 25, 2023
    Drs. Lawhern and Nadeau Explain Overdose Mortality Data

    Drs. Lawhern and Nadeau Explain Overdose Mortality Data

    November 23, 2023
    A conversation with Dr. Gavin Francis

    A conversation with Dr. Gavin Francis

    November 20, 2023
  • Surveys

    Surveys

    Should guided yoga and breathing exercise (pranayama) classes be covered by your health insurance?

    Should guided yoga and breathing exercise (pranayama) classes be covered by your health insurance?

    November 29, 2023
    How often do you distrust healthcare news

    How often do you distrust healthcare news?

    October 30, 2023

    Survey Results

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Lewis, a Pain Specialist who has seen it all

    A conversation with Dr. Lewis, a Pain Specialist who has seen it all

    December 5, 2023
    A follow-on conversation with Drs. Lawhern & Nadeau, delving deeper into opioid mortality statistics

    A follow-on conversation with Drs. Lawhern & Nadeau, delving deeper into opioid mortality statistics

    December 3, 2023
    Joseph Parker

    A conversation with Dr. Parker, a model of physician advocacy

    December 2, 2023
    Dr. Amesh Adalja Discusses Flu Season and Trends in 2024

    Dr. Amesh Adalja Discusses Flu Season and Trends in 2024

    November 25, 2023
    Drs. Lawhern and Nadeau Explain Overdose Mortality Data

    Drs. Lawhern and Nadeau Explain Overdose Mortality Data

    November 23, 2023
    A conversation with Dr. Gavin Francis

    A conversation with Dr. Gavin Francis

    November 20, 2023
  • Surveys

    Surveys

    Should guided yoga and breathing exercise (pranayama) classes be covered by your health insurance?

    Should guided yoga and breathing exercise (pranayama) classes be covered by your health insurance?

    November 29, 2023
    How often do you distrust healthcare news

    How often do you distrust healthcare news?

    October 30, 2023

    Survey Results

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

Paths of Understanding

Jay K Joshi by Jay K Joshi
August 8, 2021
in Politics & Law
1

Starting in 2020, the Centers for Disease Control and Prevention (CDC) began soliciting comments from the general public as to how it should revise the 2016 opioid prescribing guidelines.

To date the CDC received 5,392 comments – 4,150 from patients, 702 from advocates and industry groups, 431 from caregivers, and 109 from clinicians.

The CDC also engaged in 106 conversations – 42 from patients, 21 from caregivers, and 43 from physicians.

Clearly, the CDC overemphasized direct, deep conversation with physicians over broad, public comments, as only 2% of the comments came from physicians but 66% of conversations were with physicians.

This may seem obvious. Of course, physicians are less likely to engage in public postings on government sites, and of course it makes sense to get deeper input from the physicians themselves – they are ultimately the decision-makers in prescribing opioids.

Despite the limited sample size, the data reveals something quite telling. Of all the conversations in which it was disclosed that opioids had a meaningful impact on patient care, roughly half said opioids “mostly helped”.

This is in stark contrast to the national narrative that poor prescribing practices – such as overprescribing – ushered in the opioid epidemic.

The conversations contradict the narrative.

And will likely guide a radical restructuring of the guidelines to be more favorable towards patients who receive opioids. While we generally agree with this sentiment, we cannot help but wonder if the CDC would have reached the same conclusion had it encouraged more public commentary from physicians.

Generally speaking, physicians have responded to the opioid epidemic by dramatically reducing the amount of opioids prescribed – some going so far as to tout opioid-free care management. So it would appear that most physicians agree that opioids are generally harmful.

But this is not what the conversations reveal. The private conversations reveal a more positive outlook for opioids, creating an interesting paradox between the public response and the private disclosures among physicians.

Which begs the question, why are private conversations with physicians contradicting the public perception touted among physicians?

Some may say physicians are being disingenuous publicly. Instead, we believe physicians are easily influenced.

Most physicians follow the prevailing narrative without much thought. Their understanding of the opioid epidemic was as influenced by the predominant narrative as the general public.

But physicians – being physicians – recontexualized the narrative into clinical terms, retrofitting the predominant belief into how they think clinically.

As a result, we saw a slew of clinical studies and thought leadership papers highlighting the clear and present danger of opioids. Just like we saw a slew of clinical studies and thought leadership papers highlighting the clear and present danger of poorly controlled pain two decades ago.

There is the data, and then there is the perception of the data. The studies we publish utilize data in ways that reflect the perceptions we hold – we are innately biased.

This explains there is disconnect between why we make decisions, and the justifications we claim for those decisions.

And why what physicians say publicly about opioids differs from what they say privately.

The implicit biases physician hold created the disparity between the intention of the 2016 guidelines and its implementation.

Now that we have the opportunity to revise the guidelines, the CDC would be remiss if it did not account for these biases.

Constructing guidelines that address more subtle, fundamental aspects of clinical decision-making – identifying paths of understanding for physicians.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Comments 1

  1. NORMAN CLEMENT says:
    2 years ago

    BLOOD MONEY: THE GREAT OPIOID CRISIS QUACKERY AND WHY

    https://youarewithinthenorms.com/2021/07/23/blood-money-the-great-opioid-crisis-quackery-and-why-medical-scientist-chronic-pain-patients-and-walmart-are-waging-war-against-the-dea-doj-from-extorting-billions-of-dollars-from-drug-manufacturer/

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

Dr. Adalja shares his thoughts on the current flu season and future trends in viral infectious diseases. He talks about vaccine misinformation and what he expects to see in 2024.

Dr. Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security, an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health, and an Affiliate of the Johns Hopkins Center for Global Health. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity.

https://centerforhealthsecurity.org/who-we-are/our-people/amesh-adalja-md-fidsa

Twitter: @AmeshAA

Instagram: @ameshadalja


#COVID #RSV #influenza #misinformation #disinformation #vaccines #trust
Dr. Amesh Adalja Discusses Flu Season and Trends in 2024
YouTube Video rSipAzS4d90
Subscribe

How does Congress learn about health issues?

Visuals

A Two Headed Monster - State Attorneys General and the Drug Enforcement Agency

DEA driven production cuts of prescription opioids

by Jay K Joshi
November 15, 2023
0

We highlight a figure from patient advocate, Monty Goddard's article, A Two Headed Monster – State Attorneys General and the Drug Enforcement Agency.

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • A Call to Action for Pain Patients and Advocates

    A Call to Action for Pain Patients and Advocates

    1 shares
    Share 0 Tweet 0
  • A Two Headed Monster – State Attorneys General and the Drug Enforcement Agency

    0 shares
    Share 0 Tweet 0
  • Unraveling How Patients Lose Credibility with Their Physicians

    0 shares
    Share 0 Tweet 0
  • Healthcare is Health Justice

    0 shares
    Share 0 Tweet 0
  • Focusing on the Jury Instruction on Drug Conspiracy at My Trial

    1 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do